Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)
-
Upload
vall-dhebron-institute-of-research-vhir -
Category
Health & Medicine
-
view
772 -
download
1
description
Transcript of Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)
![Page 1: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/1.jpg)
Oxidative stress and atrial fibrillation: a long journey into the clinic?
Barbara Casadei MD DPhil FRCP British Heart Foundation Professor of Cardiovascular Medicine& Hon Consultant Cardiologist
Department of Cardiovascular MedicineBHF Centre of Research ExcellenceUniversity of Oxford
VHIR Seminar30 April 2013
![Page 2: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/2.jpg)
AF: epidemiology & treatment
• Most common sustained clinical arrhythmia (1:4 lifetime risk)
![Page 3: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/3.jpg)
AF: epidemiology & treatment
• Most common sustained clinical arrhythmia (1:4 lifetime risk)
• AF is associated with a significantly increased mortality and high medical costs (ca. 3% of the UK NHS budget)
![Page 4: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/4.jpg)
AF: epidemiology & treatment
• Most common sustained clinical arrhythmia (1:4 lifetime risk)
• AF is associated with a significantly increased morbidity and with high medical costs (ca. 3% of the NHS budget)
• Available treatment is suboptimal (targeted to symptoms and prevention of thromboembolism)
![Page 5: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/5.jpg)
Mortality after incident AF in 1993-2007Piccini et al. Circulation: Cardiovascular Quality and Outcomes. 2012
1993 1997 2003 20070
5
10
15
20
25
30
35
Mortality trends for coronary heart disease in the USA
Prevalence of AF 1993-2007
![Page 6: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/6.jpg)
‘AF begets AF’Wijffels et al, 1995
Short APD & loss of rate adaptation promote re-entry
200 ms
SRAF
![Page 7: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/7.jpg)
Targeting ion channels (conduction and excitability)
Therapeutic strategies aimed at molecular
targets that are upstream or
independent of ion channels
![Page 8: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/8.jpg)
Oxidative stress and atrial remodelling in AF
ATRIAL FIBRILLATION
ATRIAL FIBRILLATION
RAPID ATRIALACTIVATION
RAPID ATRIALACTIVATION
ELECTRICALREMODELLING
ELECTRICALREMODELLINGAF begets AF
+
OXIDATIVE
STRESS
OXIDATIVE
STRESS
![Page 9: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/9.jpg)
Atrial oxidative stress and AF
• There is evidence of oxidative injury in atrial samples from patients with AF (Mihm et al. Circ 2001)
• There is a correlation between oxidative stress and atrial ERP shortening in animal models (Carnes et al. Circ Res 2004)
• Treatment with anti-oxidant/anti-inflammatory agents prevents atrial electrical remodelling and AF induction in a dog model of atrial tachypacing (Carnes et al. Circ Res 2001, Shiroshita-Takeshita et al. Circ Res 2004)
![Page 10: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/10.jpg)
.NAD(P)H
p22phox
racp67phox
p47phox
O2
NAD(P)+
H+
NOX2
.O2-
NC p67phoxp47phox
Test
Phase
Stain
Contrast
Immunolocalization in human atrial myocytes
atrial myocytesRAA
47kD
67kDAnti-p67phox
Anti-p47phox
Anti-p22phox
+
22kD
Immunoblotting
A NOX2 oxidase in human atrial cellsKim et al, Circ Res 2005
![Page 11: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/11.jpg)
Atrial NOX2 activity is increased in patients with (mostly) PAF
*
0
2
4
6
SR PAF
NO
X2
acti
vity
(R
LU
/sec
/mg
pro
tein
)
Kim et al, Circ Res 2005
![Page 12: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/12.jpg)
NOX2 activity is increased in the LA of goats after 2 weeks of AF
0.0
0.1
0.2
0.3
0.4
Right Atrium Left Atrium
*
O2
- (RLU
/s/
g pr
otei
n)
Reilly et al. Circulation 2011
RA LA RA LA
NOX2
GAPDH
SR AF
![Page 13: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/13.jpg)
R² = 0.25
0
0.2
0.4
0.6
0.8
1
0 50 100 150 200 250
Elevated atrial NOX2 activity is associated with shortening of the atrial effective refractory period
Reilly et al. unpublished data
Atrial effective refractory period (ms, measured at CL=300 ms)
Atria
l NO
X2 a
ctivi
ty (R
LU/m
g pr
otei
n)
![Page 14: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/14.jpg)
• NOX2 oxidases are present in the human atrial myocardium
• Atrial NOX2 activity is increased in AF and correlated with the extent of the AF-induced atrial electrical remodelling
• Does an increase in atrial NOX2 activity precede AF?
?
Atrial NOX2 activity and AF: cause or effect?
![Page 15: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/15.jpg)
• Atrial fibrillation is a frequent complication of most types of cardiac surgery, occurring in 35-50% of patients within the first 2-5 postoperative days
• The inflammatory reaction associated with cardiac surgery and cardiopulmonary bypass has been implicated in the genesis of this arrhythmia
• NOX2 activity is stimulated by cytokines
Post-operative atrial fibrillation
![Page 16: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/16.jpg)
Hypotheses:
• Atrial NOX2 oxidases may “sense” systemic inflammation and translate it into a local increase in oxidative stress leading to arrhythmogenesis
•Atrial NOX2 activity may predict the occurrence of postoperative AF
![Page 17: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/17.jpg)
Study protocol• 170 patients undergoing first-time on pump CABG
• Exclusion criteria: history of AF, valvular disease, use of anti-arrhythmic drugs other than beta-blockers
• Atrial NADPH-stimulated superoxide production was measured by lucigenin-enhanced chemiluminescence in a sample of the RAA obtained prior to the initiation of CPB.
• Plasma markers of protein & lipid oxidation (TBARS, protein carbonyls, isoprostanes) were measured in blood samples obtained after the induction of anaesthesia and 10 minutes after the administration of protamine.
Kim et al JACC 2008
![Page 18: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/18.jpg)
Plasma markers of systemic oxidative stress and post-operative AF
Post-Op
* *
TBARS Protein Carbonyls0
0.2
0.4
0.6
0.8
1
Pre-Op
Pre-Op
SRAF
Pla
sma
mar
kers
of
oxi
dat
ive
stre
ss
(nm
ol/
ml)
SRAF
SR AF
SR AF
Post-Op
* *
![Page 19: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/19.jpg)
Atrial NOX2 activity is independently associated with a higher incidence of post-operative AF (n=170)
OR 95% CI PAge 1.01 0.95-1.08 0.69
Atrial NOX2 activity (RLU/sec/mg protein)
2.61 1.61-4.23 0.00003
TBARS (pre) 0.12 0.01-2.29 0.16TBARS (post) 4.90 0.48-48.96 0.18Carbonyls (pre) 0.55 0.02-13.08 0.71Carbonyls (post) 2.12 0.20-22.11 0.53Diabetes 0.89 0.31-2.60 0.83Beta-blockers 2.63 0.76-9.13 0.13ACEI/ARB 1.56 0.59-4.10 0.37
Kim et al JACC 2008
![Page 20: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/20.jpg)
Atrial NOX2 activity is an independent predictor of new-onset AF after cardiac surgery (n=281)
Cox-regression (HR[95%CI], P):Lowest tertile: RefMid tertile: 3.15[1.06-9.4], P=0.039Highest tertile: 6.43[2.10-19.69], P=0.001
Post-operative days
1
0.8
0.6
0.4
0.2
00 4 8 121062 14 16
AF
-fre
e s
urv
iva
l
Antoniades et al. JACC 2011
Tertiles of atrial NOX2 activity HighestMidLowest
![Page 21: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/21.jpg)
Atrial NOX2 activity is a predictor of in-hospital outcome after cardiac surgery
HighestMidLowest
Atr
ial
NO
X2
acti
vity
(RLU
/sec
/mg
prot
ein)
12x104
8x104
4x104
2x104
0
6x104
10x104
P=0.0001
0 1 ≥2Inotropic support (days)
Post-operative days
0
0.2
0.4
0.6
0.8
1
0 5 10 15 20 25 30
Ho
spit
al d
isch
arg
e
Cox-regression (HR[95%CI], P):
Lowest: Ref
Mid: 0.78[0.53-1.17], P=0.234
Highest: 0.61[0.39-0.93], P=0.02
Antoniades et al. JACC 2011
Tertiles of atrial NOX2 activity
![Page 22: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/22.jpg)
• NOX2 oxidases are present in the human atrial myocardium
• Atrial NOX2 activity is increased in AF and correlated with the extent of the AF-induced atrial electrical remodelling
• An increase in atrial NOX2 activity precedes AF
• Is increased atrial NOX2 activity sufficient to create a substrate for AF?
.
.
Atrial NOX2 activity and AF: cause or effect?
![Page 23: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/23.jpg)
LA
RA
oesophagus
electrodes
trachea
Octapolar transeosophageal catheter
2% isoflurane
ECG electrode 1
ECG electrode 2
ECG electrode 3
ECG electrode 4
Atrial burst stimulation in the mouse
![Page 24: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/24.jpg)
WT nNOS-KO0
1
2
3
4
5
Num
ber
of
AF
epi
sode
s
WT mNOX2 Tg
WT nNOS-KO0
5
10
15
20
Pro
babili
ty o
fA
F in
duc
tion
(%)
0.2 secondsCha
nnel
4-E
CG
Volts
3
2
10.2 secondsC
hann
el 4
-EC
GVo
lts
3
2
1
Cha
nnel
4-E
CG
Vol
ts
3
2
10.2 secondsC
hann
el 4
-EC
GV
olts
3
2
10.2 seconds
AF
Normal sinus rhythm
n=10-13
Myocardial-specific overexpression of NOX2 increases AF inducibility in vivo in mice
WT mNOX2 TgRecalde et al, unpublished data
![Page 25: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/25.jpg)
P Niethammer et al. Nature 2009
![Page 26: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/26.jpg)
Atrial NOX2 activity and AF: cause or effect?
• NOX2 oxidases are present in the human atrial myocardium
• Atrial NOX2 activity is increased in AF and correlated with the extent of the AF-induced atrial electrical remodelling
• An increase in atrial NOX2 activity precedes AF
• Increased atrial NOX2 activity is sufficient to create a substrate for AF
• Do pharmacological interventions that inhibit NOX2 activity prevent AF?
.
.
.
![Page 27: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/27.jpg)
p22phox
O2
NOX2
NOX2 NADPH oxidases: activated by cytokines and AngII
NADPH NADP + H+
O2-
rac
p67phox
p47phox
![Page 28: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/28.jpg)
p67phoxp47phox
p22phox
O2
NOX2
rac
STATINS
Statin-mediated inhibition of NOX2
![Page 29: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/29.jpg)
Postop AF Postop SR
p47phox
GTP-Rac1
- +
Total Rac1
p47phox
GAPDH
GTP-Rac1
Total Rac1
p67phox
AtorvastatinMevalonateAtorvastatinMevalonate - +
++--
- +++
--
0
1
2
3
AtorvastatinMevalonate -
--
++
+--
-++
+
* * *#G
TP
-Rac
1/to
tal R
ac1
Postop AF Postop SR
p67phoxp47phox
p22phox
O2
NOX2
rac
STATINS
Atrial Rac1 activity is increased in patients who develop post-operative AF and is inhibited by atorvastatin
![Page 30: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/30.jpg)
0.2 secondsCha
nnel
4-E
CG
Volts
3
2
10.2 secondsC
hann
el 4
-EC
GVo
lts
3
2
1
Cha
nnel
4-E
CG
Vol
ts
3
2
10.2 secondsC
hann
el 4
-EC
GV
olts
3
2
10.2 seconds
Atorvastatin treatment inhibits AF inducibility in mNOX2 Tg mice
Recalde et al, unpublished data
![Page 31: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/31.jpg)
Effect of peri-operative statin treatment on post-operative AF
Chen et al. J Thorac Cardiovasc Surg. 2010
![Page 32: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/32.jpg)
• A double-blind, randomised, placebo-controlled trial of perioperative Rosuvastatin (20 mg od)
• Treatment is started 3-7 days before surgery and continued until the 5th post-operative day
• 1800 patients undergoing cardiac surgery
•1350 patients recruited so far.
Prevention of myocardial damage and post-operative atrial fibrillation in patients undergoing cardiac surgery.
![Page 33: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/33.jpg)
Effect 3-day preoperative treatment with atorvastatin (20 mg od vs. placebo) on atrial and vascular redox state in 42 CABG patients
IMA
NO
X2 A
ctiv
ity
Antoniades et al. JACC 2011Antoniades et al. Circulation 2011
Atr
ial N
OX2
Act
ivity
2x104
4x104
6x104
8x104
10x104
(RLU
/sec
/mg
prot
ein)
3d-Placebo 3d-Atorva0
**
![Page 34: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/34.jpg)
Primary ObjectivesTo establish whether perioperative administration of Rosuvastatin
leads to a reduction in: • the incidence of post-operative AF (as assessed by
continuous ECG monitoring) • perioperative myocardial injury (as assessed by serial
Troponin measurements).
![Page 35: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/35.jpg)
Secondary Objectives• In-hospital clinical outcomes:
– Hospital and intensive care unit stay– Major in-hospital cardiac or cerebrovascular events
• Biomarkers:–Myocardial oxidase activity and serum CD40L, NT-proBNP, lipids,
and renal function.
• LV function by echocardiography
![Page 36: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/36.jpg)
First 850 patients (mean age 59±10 yrs, LVEF 60±8%)
Previous MI
Previous stroke/TIA
Diabetes
Heart Failure
Beta-blockers
Antiplatelets/Anticoagulants
ACEI/ARB
Nitrates
STATINS
On pump surgery
0 10 20 30 40 50 60 70 80 90 100
RosuvasatinPlacebo
%
![Page 37: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/37.jpg)
What will we learn?
• Is aggressive statin treatment in the perioperative period beneficial?
• Are statins cardioprotective and anti-arrhythmic in these patients?
• Are the pleiotropic effects of statins (e.g., NOX2 inhibition) clinically relevant?
![Page 38: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/38.jpg)
Svetlana ReillyXing LiuAlice RecaldeRicardo CarnicerRaja Jayaram
Keith ChannonCharis Antoniades(Cardiovascular Medicine)
Rana SayeedMario PetrouRavi DeSilva (Cardiothoracic Unit)
Blanca RodriguezAlfonso Bueno(Computer Science)
Rory CollinsZhengming ChenJonathan Emberson
Zhe ZhengLixin Jiang(CTSU & Fuwai Hospital)
Manuela Zaccolo(DPAG, Oxford)
Uli SchottenSander Verheule(Maastricht University)
Ajay ShahPhil Eaton(King’s College)
Emilio Hirsch(University of Turin)
![Page 39: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/39.jpg)
![Page 40: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/40.jpg)
Stroke, Cholesterol and Statins
![Page 41: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/41.jpg)
To assess the effects of Atorvastatin 80mg od on the atrial effective refractory period (over 5 post-operative days) and myocardial ischemia/reperfusion injury in paired right atria samples in patients undergoing cardiac surgery
60 of a planned 80 patients have been randomised (mean age 65 yrs, range from 41 to 80 yrs, 79% males) to atorvastatin 80 mg od vs. placebo. 40% developed post-op AF.
STARR Statin Treatment on Atrial Refractoriness & Reperfusion injury
![Page 42: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/42.jpg)
Effects of rosuvastatin on atrial fibrillation occurrence: ancillary results of the GISSI-HF trial
Maggioni et al. Eur Heart J 2009
![Page 43: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/43.jpg)
Does atrial ROS production or its enzymatic sources vary with the duration
and substrate of AF?
…and might this affect the efficacy of statins in the prevention of AF?
![Page 44: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/44.jpg)
Atrial sources of oxidative stress change with the duration of AF and the presence of atrial structural remodelling
0.0
0.1
0.2
0.3
0.4
Right Atrium Left Atrium
**
O2
- (RLU
/s/
g p
rote
in)
6M AF (n=10)
0.0
0.1
0.2
0.3
0.4
0.5
Right Atrium Left Atrium
**
O2
- (RLU
/s/
g p
rote
in)
AV block (n=9)
0.00
0.05
0.10
0.15
0.20
0.25
Sinus Rhythm Chronic Atrial Fibrillation(Right Atrium)
**
O2- (R
LU/s
/ g
pro
tein
)
Chronic AF (n=26) vs. SR in humans (n=72)
p22phox
GAPDH
GAPDH
CAFP-op AFSR
NOX2
Reilly et al. Circulation 2011
![Page 45: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/45.jpg)
L-Arginine + O2
Citrulline + NO
Increased atrial superoxide release in chronic AF is associated with an increase in Mito complexes and uncoupled NOS activity
- +
NOX5GAPDH
- +
NOX4GAPDH
- +SR CAFNOX2
GAPDH
GAPDH
VDAC
Mito
chon
dria
l co
mpl
exes
V
IV
III
II
I
SR CAF
GAPDH
VDAC
V
IV
III
II
I
O2
.O-2
0.0
0.1
0.2
0.3
0.4
Right Atrium Left Atrium
**
O2
- (RLU
/s/
g p
rote
in)
![Page 46: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/46.jpg)
Summary• The main source of superoxide production in the human
atrial myocardium is a membrane-bound NOX2 oxidase
• Both atrial rac1 and NOX2 activity are increased in animal models of short-term AF and in patients who develop AF after cardiac surgery
•Atrial NOX2 activity is an independent predictor of post-operative AF
• An increase in myocardial NOX2 activity is sufficient to create a substrate for AF induction
• Atrial NOX2 is a promising pharmacological target for AF prevention
![Page 47: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/47.jpg)
NOS uncoupling in the RA myocardium is due to an ipsilateral reduction in BH4 and increase in arginase activity
RA LA RA LA RA LA RA LA
0.0
0.5
1.0
1.5
2.0
2.5
*
SR AVB6M-AF2W-AF
†
BH
4 (p
mo
l/mg
)
0
10
20
30
40
50
0 100 200 300 400 500 600 7004 4.25 4.5 5 5.25 5.5Minutes
mV
*4.3
SR
6M-AF
00
10
20
30
40
50
0 100 200 300 400 500 600 7004 4.25 4.5 5 5.25 5.5Minutes
mV
*4.3
SR
6M-AF
0
10
20
30
40
50
0 100 200 300 400 500 600 7004 4.25 4.5 5 5.25 5.5Minutes
mV
*4.3
SR
6M-AF
0
10
20
30
40
50
0 100 200 300 400 500 600 7004 4.25 4.5 5 5.25 5.5Minutes
mV
*4.3
SR
6M-AF
0
BH4
RA LA RA LA RA LA RA LA
0
5
10
15
20
25 *
SR AVB6M-AF2W-AF
†
#
L-or
nith
ine
(%)
-10
0
10
20
30
40
50
60
0 30 60 90 12017 1816
SR
6M-AF
16.25 16.5 17.25Minutes
mV
-10
0
10
20
30
40
50
60
0 30 60 90 12017 1816
SR
6M-AF
16.25 16.5 17.25-10
0
10
20
30
40
50
60
0 30 60 90 12017 1816
SR
6M-AF
16.25 16.5 17.25Minutes
mV
0
-10
0
10
20
30
40
50
60
0 30 60 90 12017 1816
SR
6M-AF
16.25 16.5 17.25Minutes
mV
-10
0
10
20
30
40
50
60
0 30 60 90 12017 1816
SR
6M-AF
16.25 16.5 17.25-10
0
10
20
30
40
50
60
0 30 60 90 12017 1816
SR
6M-AF
16.25 16.5 17.25Minutes
mV
0
L-ornithine
![Page 48: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/48.jpg)
Prevention of coronary events by statins is due to sustained LDL cholesterol lowering
![Page 49: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/49.jpg)
Secondary Objectives• In-hospital clinical outcomes:
– Hospital and intensive care unit stay– Major in-hospital cardiac or cerebrovascular events
• LV function by echocardiography• Biomarkers:
–Myocardial oxidase activity, markers of inflammation, NT-proBNP, lipids, and renal function.
![Page 50: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/50.jpg)
A higher preoperative serum level of the proinflammatory and prothrombotic CD40-ligand (sCD40L) is associated with a greater
risk of postoperative AF
AFSR
sCD4
0L (n
g/m
l)
01234567 P<0.05
In hospitalAFSR
At 6 weeks
P<0.05
01234567
sCD4
0L (n
g/m
l)N=147 patientsRR for highest vs lowest sCD40L tertile = 3.81, 95% CI: 1.12-12.95, P<0.05
Antoniades et al. Circulation 2008
Platelet activation and prothrombotic
state may p
recede (and promote?) the
onset of AF
![Page 51: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/51.jpg)
Gudbjartsson et al. Nat Genet. 2009
![Page 52: Oxidative stress and atrial fibrillation: a long journey in to the clinic? (Prof. Barbara Casaidei)](https://reader036.fdocuments.net/reader036/viewer/2022062319/556ef718d8b42ad36d8b513f/html5/thumbnails/52.jpg)